Mirum (MIRM) PT Raised to $140 at Citizens: Outperformance Expeected
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben raised the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $140.00 (from $95.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
